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The contribution of different leptin-induced sig-
naling pathways in control of energy homeosta-
sis is only partly understood. Here we show that
selective Pten ablation in leptin-sensitive neu-
rons (PtenDObRb) results in enhanced Pi3k acti-
vation in these cells and reduces adiposity by
increasing energy expenditure. White adipose
tissue (WAT) of PtenDObRb mice shows charac-
teristics of brown adipose tissue (BAT), re-
flected by increased mitochondrial content
and Ucp1 expression resulting from enhan-
ced leptin-stimulated sympathetic nerve activ-
ity (SNA) in WAT. In contrast, leptin-deficient
ob/ob-PtenDObRb mice exhibit unaltered body
weight and WAT morphology compared to
ob/ob mice, pointing to a pivotal role of endog-
enous leptin in control of WAT transdifferentia-
tion. Leanness of PtenDObRb mice is accompa-
nied by enhanced sensitivity to insulin in
skeletal muscle. These data provide direct
genetic evidence that leptin-stimulated Pi3k
signaling in the CNS regulates energy expendi-
ture via activation of SNA to perigonadal WAT
leading to BAT-like differentiation of WAT.
INTRODUCTION
The discovery that the hormone leptin is secreted from
adipose tissue and acts through receptors expressed in
the hypothalamus to inhibit food intake and stimulate
energy expenditure has provided a prototype for homeo-Cell Mestatic signals integrating the energy state of peripheral or-
gans with the action of the central nervous system (Halaas
et al., 1995). The actions of leptin are mediated through the
long isoform of the leptin receptor (ObRb), which is pre-
dominantly expressed in hypothalamic nuclei involved in
the regulation of energy homeostasis (Elmquist et al.,
1998; Fei et al., 1997). Intracerebroventricular (icv) injec-
tion of leptin results in reduced expression of orexigenic
(appetite-inducing) and increased expression of anorexi-
genic (appetite-suppressing) hypothalamic neuropep-
tides (Schwartz et al., 1992; Sipols et al., 1995) and leads
to acute inhibition of food intake and activation of the sym-
pathetic nervous system (Air et al., 2002). Nevertheless,
the relative contribution of different intracellular signaling
pathways in mediating its pleiotropic effects in energy ho-
meostasis is only partly understood.
One of the major pathways activated by the cytokine-
type leptin receptor is the Jak-Stat3 pathway inducing
the transcription of Stat3 target genes. The importance
of leptin-stimulated Stat3 activation has been demon-
strated by numerous experimental approaches. For ex-
ample, point mutations in the Stat3-binding tyrosine resi-
due in the leptin receptor in knockin mice have provided
direct evidence for the importance of this pathway in lep-
tin’s activity to suppress food intake (Bates et al., 2003).
Moreover, both brain-specific and Pomc-neuron-res-
tricted inactivation of Stat3 result in obesity and hyper-
phagia (Gao et al., 2004; Xu et al., 2007). These data
clearly indicate that leptin-stimulated Stat3 activation
plays a pivotal role in leptin-induced suppression of food
intake.
Besides activating the Jak-Stat pathway, the leptin re-
ceptor also engages the activation of the Pi3-kinase
(Pi3k) pathway via Jak2-mediated tyrosine phosphoryla-
tion of insulin receptor substrate (IRS) proteins. Con-
versely, icv-administered Pi3k inhibitors blunt the acutetabolism 6, 431–445, December 2007 ª2007 Elsevier Inc. 431
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ObRb-Specific Pten Knockout Miceanorectic action of icv-applied leptin (Niswender et al.,
2001). These experiments indicate that Pi3k activation is
also involved in mediating leptin’s anorectic action. Re-
cent studies have provided at least two mechanisms for
how Pi3k activation affects feeding. First, Pi3k activation
triggers activation of phosphodiesterase (PDE)-3B, which
appears to be a prerequisite for leptin-stimulated Stat3
activation (Zhao et al., 2002). More recently, Pi3k-medi-
ated inactivation of the forkhead transcription factor
FoxO-1 was demonstrated to be required for leptin-stim-
ulated expression of proopiomelanocortin (Pomc) and in-
hibition of Agouti-related peptide (AgRP) (Kitamura et al.,
2006). Nevertheless, the molecular mechanisms for how
leptin promotes energy expenditure as well as whether
this effect is primarily mediated by central or peripheral
leptin action are currently unclear. To better define the
contribution of central Pi3k signaling in leptin action in en-
ergy homeostasis and peripheral glucose metabolism, we
have developed a mouse model with enhancement of Pi3k
signaling specifically in cells expressing ObRb in the cen-
tral nervous system (CNS).
RESULTS
Generation of PtenDObRb Mice
Overactivation of the Pi3k pathway was mimicked by
deletion of the PIP3 phosphatase Pten. To inactivate the
Pten gene specifically in ObRb-expressing neurons, we
crossed mice carrying the loxP-flanked (floxed) Pten allele
(Suzuki et al., 2001) with mice expressing the Cre-recom-
binase from an IRES element inserted into the 30 untrans-
lated region of the ObR gene (DeFalco et al., 2001). Thus,
Cre activity was only present in cells in which splicing of
ObRb occurred. To visualize Cre-mediated recombina-
tion, we additionally crossed the ObRbCre mice with the
LacZ/EGFP (Z/EG) reporter mouse strain, which carries
a transgene comprising a loxP-flanked b-galactosidase/
neomycin-resistance (bgeo) fusion gene followed by the
coding sequence of the enhanced green fluorescent
protein (EGFP) (Novak et al., 2000). In this configuration,
b-galactosidase is expressed before Cre excision and
EGFP (herein after referred to as GFP) is expressed after
Cre excision. Immunohistochemical analyses of hypotha-
lamic sections of double-heterozygous ObRbCre-Z/EG
mice detected GFP expression in the ARC region as well
as in the ventromedial (VMH) and dorsomedial (DMH) hy-
pothalamic nuclei (Figure 1A). Consistent with the known
ObR expression pattern, GFP/Pomc and GFP/AgRP dou-
ble-immunohistochemical staining of ARC slices identi-
fied some of the ObRb-expressing neurons to be either
Pomc or AgRP neurons, respectively (Figure 1B).
No GFP expression was found in other brain regions
(Figure 1C) or peripheral tissues (liver, white/brown adi-
pose tissue, pancreas, skeletal muscle; Figure 2A). In
striking contrast, Z/EG mice expressing Cre recombinase
ubiquitously in the developing embryo (deleter Cre) ex-
hibited immunohistochemically detectable GFP expres-
sion in the entire CNS and in all peripheral tissues tested432 Cell Metabolism 6, 431–445, December 2007 ª2007 Elsevie(Figure 2A). These experiments confirmed the specificity
of GFP expression in ObRbCre-Z/EG mice.
To further confirm the specificity of ObRb-restricted
Pten inactivation, we prepared protein extracts from brain
of Ptenlox/lox (control, Co) and ObRbCre-Ptenlox/lox (ObRb-
specific Pten knockout, PtenDObRb) mice and subse-
quently analyzed Pten protein expression. Western blot
analysis with a Pten-specific antiserum revealed no alter-
ations in overall brain Pten protein expression (Figure 2B),
consistent with the idea that Pten inactivation occurs only
in a relatively low number of ObRb-expressing cells.
Moreover, Pten protein expression in peripheral tissues
such as liver, pancreas, white adipose tissue, and skeletal
muscle remained unaltered in PtenDObRb mice as com-
pared to controls (Figure 2B). Pten deletion in skeletal
muscle or liver is known to result in enhanced insulin-stim-
ulated Akt activation in these organs. To further study
whether Pten activity was functionally altered in these or-
gans, we directly assessed insulin-stimulated phosphory-
lation of Akt in liver and skeletal muscle of control and
PtenDObRb mice. These analyses revealed unaltered basal
and insulin-stimulated Akt phosphorlyation in these or-
gans of PtenDObRb mice (Figure S1 available with this arti-
cle online), thus further supporting the suggestion that
Pten deletion had not occurred in these organs. Further-
more, we performed Southern blot analyses (Suzuki
et al., 2001) using HindIII-digested adipose-tissue DNA,
ruling out the possibility of significant Cre-mediated re-
combination in white (WAT) and brown (BAT) adipose tis-
sue and liver (Figures 2C and 2D).
Thus, several complementary experimental approaches
indicate that Cre-mediated recombination in ObRbCre
mice occurs only in defined hypothalamic, leptin-respon-
sive neurons but not in peripheral tissues, as previously
reported to express the ObRb isoform.
We next analyzed leptin’s ability to activate Akt phos-
phorylation in hypothalamic neurons of PtenDObRb and
control mice to further determine the functional effect of
ObRb-specific Pten deficiency on activation of the Pi3k
pathway in the hypothalamus. Immunohistochemical
staining for pAkt revealed low pAkt immunoreactivity in
hypothalami of control mice under basal conditions (sa-
line) and upon leptin stimulation (Figures 2E and 2F). In
contrast, leptin increased pAkt immunoreactivity in a dis-
tinct population of ARC neurons and in a few VMH neurons
in hypothalami of PtenDObRb mice (Figures 2E and 2F).
On the other hand, basal (saline) and leptin-stimulated
pStat3 formation in the hypothalamus, as assessed by
immunohistochemistry, was unchanged in PtenDObRb
mice (Figures 2G, 2H and S2A). These data indicate that
ObRb-specific inactivation of the Pten gene selectively
enhances activation of the Pi3k/Akt pathway in those brain
regions, where ObRb-expressing neurons are present.
Leanness in PtenDObRb Mice
To assess the impact of activated PIP3-dependent signal-
ing in leptin-responsive hypothalamic neurons on energy
homeostasis, we first determined body weight of control
and PtenDObRb mice. Both PtenDObRb males and femalesr Inc.
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ObRb-Specific Pten Knockout MiceFigure 1. Generation of ObRb-Specific Pten Knockout and Reporter Mice—Selective Activation of the Pi3k Pathway in ObRb-
Expressing Neurons of PtenDObRb Mice
(A) Cre-mediated recombination was visualized by immunohistochemistry for GFP in hypothalamic series of double-heterozygous reporter mice
(ObRbCre-Z/EG) at age 10 weeks. Cre-recombinase activity is present in the arcuate (ARC), ventromedial (VMH), and dorsomedial (DMH) hypotha-
lamic nucleus. GFP-positive cells are brown. Scale bar: 100 mm.
(B) Double-immunohistochemical staining for GFP/Pomc (left panels) and GFP/AgRP (right panels) in hypothalami of double-heterozygous reporter
mice (ObRbCre-Z/EG). Green (upper panels), GFP; red (mid panels), Pomc (left), or AgRP (right); yellow (bottom panels, merged images), double-pos-
itive neurons, indicated by the small arrows. Scale bars: 20 mm (AgRP) and 10 mm (Pomc). Note the presence of projecting fibers, which are positive for
GFP and AgRP (right panels, indicated by the long arrow). Scale bar: 10 mm.
(C) To visualize Cre-mediated recombination, immunohistochemistry for GFP was performed in brains of double-heterozygous reporter mice
(ObRbCre-Z/EG) at ca. 6 weeks. GFP-positive cells are brown. The arrows depict isolated GFP-positive cells or fibers outside of the ARC. Scale
bar: 100 mm.Cell Metabolism 6, 431–445, December 2007 ª2007 Elsevier Inc. 433
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ObRb-Specific Pten Knockout Micehad lower body weights as compared to their control litter-
mates (Figure 3A) with no significant difference in body
length (data not shown). Moreover, relative perigonadal
fat pad weight as an indicator for body fat content was
markedly reduced in PtenDObRb mice (Figure 3B).
Analysis of energy homeostasis parameters in
PtenDObRb mice in vivo revealed unaltered steady-state
food intake over a 3 week period as well as unaltered
food intake during refeeding after a 20 hr fast (Figures
3C and 3D). Moreover, although spontaneous locomo-
tor activity did not significantly differ from controls
(Figure 3E), PtenDObRb mice showed a marked increase
in O2 consumption (Figure 3F), revealing an increased
(basal) metabolic rate in PtenDObRb mice. Thus, reduced
body weight in PtenDObRb mice appears to be the result
of increased energy expenditure in the absence of suf-
ficiently compensatory hyperphagia.
As leptin receptors are highly abundant in the ARC, and
disruption of the PIP3 phosphatase Pten in ObRb-ex-
pressing cells results in increased energy expenditure,
we next directly analyzed by quantitative RT-PCR the ex-
pression of anorexigenic (Pomc/a-MSH, CART) and orexi-
genic (NPY, AgRP) hypothalamic neuropeptides as well as
the a-MSH target peptide corticotropin-releasing hor-
mone (CRH), which is expressed in second-order neurons
of the paraventricular hypothalamic nucleus (PVN), in
whole-hypothalamus RNA extracts. These analyses did
not reveal any significant alteration in neuropeptide ex-
pression of PtenDObRb as compared to control mice
(Figure S2B), indicating that increased energy expenditure
in PtenDObRb mice occurs in the absence of marked alter-
ations in hypothalamic neuropeptide expression.
WAT to BAT Transdifferentiation in PtenDObRb
Mice
Besides the drastic reduction in mass, perigonadal WAT
of PtenDObRb mice displayed a more reddish color as com-
pared to WAT of control mice (Figure 3B). Gross histomor-
phological assessment revealed a significant reduction ofCell Metthe mean adipocyte size, which was further characterized
by the absence of large adipocytes in perigonadal WAT of
PtenDObRb mice (Figures 4A, 4B, and S3A). Immunohisto-
chemical staining of WAT for Ucp1 revealed unexpectedly
high levels of immunoreactive Ucp1 in WAT of PtenDObRb
mice (Figure 4C). Remarkably, adipocytes with multiple
vacuoles—morphologically resembling brown adipo-
cytes—were present in the perigonadal WAT of PtenDObRb
mice (Figure 4C). Consistent with the idea that WAT of
PtenDObRb mice exhibits characteristics of BAT, western
blot analyses also revealed a dramatic increase in Ucp1
expression in WAT of PtenDObRb mice compared to con-
trols (Figure 4D). Similarly, ultrastructural analyses of peri-
gonadal WAT revealed an extremely high abundance of
mitochondria in white adipocytes of PtenDObRb mice
(Figure 4E).
To test whether this transdifferentiation of perigonadal
WAT results from altered autonomous innervation, we
next measured sympathetic nervous activity (SNA) in peri-
gonadal WAT of PtenDObRb and control mice. While basal
perigonadal WAT SNA was comparable in both groups
(control 1.87 ± 0.29 V 3 s/min versus PtenDObRb 2.08 ±
0.32 V 3 s/min; p = n.s.), peripherally applied leptin in-
duced a significantly higher increase in SNA in the perigo-
nadal WAT of PtenDObRb mice (Figures 4F and 4G).
To directly address, whether leptin’s ability to activate
SNA in perigonadal WAT is mediated via enhanced leptin
action in the CNS, we analyzed the effect of intracerebro-
ventricularly applied leptin on SNA of perigonadal WAT.
Icv leptin injection led to a stronger activation than periph-
erally applied leptin in WT mice, already indicating that
central leptin action accounts for leptin’s ability to modu-
late SNA of perigonadal WAT (Figures 4G and 4H). Impor-
tantly, icv leptin administration resulted in a significantly
more pronounced SNA activation in PtenDObRb mice com-
pared to control mice (Figure 4H).
These findings are in line with the observation that Akt
phosphorylation in hypothalamic ObRb neurons as
assessed by immunohistochemistry was only slightlyFigure 2. Specificity of Pten Knockout in PtenDObRb and Reporter Mice
(A) GFP immunohistochemistry of the hypothalamus and metabolically relevant peripheral tissues, performed in an ObRbCre-Z/EG double-hetero-
zygous reporter mouse (left panels) and a DelCre-Z/EG double-heterozygous reporter mouse, which ubiquitously expresses Cre-recombinase (right
panels, positive control). WAT, white adipose tissue; BAT, brown adipose tissue.
(B) Western blot analysis of Pten and insulin receptor b subunit (loading control) in brain, liver, pancreas, white adipose tissue (WAT), and skeletal
muscle (SM) of control (Co) and PtenDObRb mice.
(C) Schematic view of the mouse Pten gene (Pten+, upper panel), the Ptenflox locus with the loxP sites (arrowheads) flanking exons (E) 4 and 5 (middle
panel), and the recombinant PtenD4–5 allele, in which E4 and E5 were excised upon Cre-mediated recombination. H, HindIII. Modified from Backman
et al. (2001).
(D) Genomic Southern blot analysis of liver, BAT, WAT, and mouse embryonic fibroblast (MEF) DNA after digestion with HindIII and hybridization with
the 1200 bp DNA probe, as shown in (C), of two PtenDObRb mice and two Ptenflox/flox mice shows no Cre-mediated recombination in adipose tissues or
liver, but the recombined Ptenflox allele is detectable in Cre-treated Ptenflox-expressing MEFs (positive control). 6.0 kb, nonrecombined Ptenflox;
2.3 kb, PtenD4–5/recombined Ptenflox allele.
(E) Immunohistochemical analysis of Akt phosphorylation (pAkt stain) in hypothalami of male mice aged 10 to 12 weeks. PtenDObRb and control (Co)
males were fasted overnight (20 hr), intravenously injected with saline or leptin (100 mg), and sacrificed after 20 min. Scale bar: 100 mm.
(F) Quantification of pAkt-positive neurons in hypothalamic series of PtenDObRb and control mice (E) after leptin injection. Values represent the average
total of pAkt-positive neurons in eight ARC slices per animal (n = 3).
(G) Immunohistochemical staining of pStat3 in hypothalami of males aged 10 to 12 weeks. Ad libitum-fed PtenDObRb and control (Co) males were
intravenously injected with saline or leptin (20 mg) and sacrificed after 30 min. Scale bar: 100 mm.
(H) Quantification of pStat3-positive neurons in hypothalamic series (average total of pStat3-positive hypothalamic neurons in the counted ARC slices)
of PtenDObRb and control mice as in (G) after leptin injection. Values represent the average total of pStat3-positive neurons in 13 ARC slices per animal
(n = 4). Filled symbols depict PtenDObRb mice, open symbols control mice. Displayed values are means ± SEM. PtenDObRb versus Co: *, p% 0.001.abolism 6, 431–445, December 2007 ª2007 Elsevier Inc. 435
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ObRb-Specific Pten Knockout MiceFigure 3. Increased Energy Expenditure and Leanness in PtenDObRb Mice
(A) Average body weights of male (triangles; n = 32–142) and female (circles; n = 16–102) PtenDObRb (filled symbols) and control (open symbols) mice
on a normal rodent chow diet.
(B) Epididymal fat pads of male control (Co) and PtenDObRb mice aged 12 weeks in situ (fat pads are indicated by the arrowheads, left panel) and after
dissection (together with the epididymal gland, middle panel). Quantification of perigonadal fat pad weights (without epididymal gland) corrected for
body weight (relative perigonadal fat pad weights, right panel, n = 12–28) of male and female mice aged 20 weeks is shown.
(C) Food intake of ad libitum-fed male (n = 5–8) and female (n = 3–4) mice, aged 10–13 weeks, on a normal rodent chow diet.
(D) Food intake during refeeding of female mice, aged 12 weeks, on a normal rodent chow diet. Values represent food intake within the first 6 hr of
refeeding following a 20 hr fast (n = 6–7).
(E) Spontaneous locomotor activity of female mice aged 12 weeks (n = 3–4).
(F) Oxygen consumption (VO2) of the same female mice as in (E).
Filled symbols depict PtenDObRb mice, open symbols control mice. Displayed values are means ± SEM. PtenDObRb versus Co: #, p % 0.05; z,
p% 0.01; *, p% 0.001.different between PtenDObRb and control mice under ba-
sal (fasted) conditions but was significantly increased in
PtenDObRb compared to control mice after leptin stimula-
tion (Figure 2E). Taken together, these data indicate that
increased Pi3k signaling in leptin-targeted neurons of
the CNS results in BAT-like transdifferentiation of WAT
as a consequence of enhanced leptin-induced SNA in
perigonadal WAT.
Analysis of ob/ob-PtenDObRb Mice
To investigate whether overactivated Pi3k signaling in
ObRb-expressing neurons and subsequent WAT transdif-
ferentiation and leanness in PtenDObRb mice depend on
leptin, we next analyzed the impact of ObRb-specific
Pten ablation in leptin-deficient ob/ob (ob/ob-PtenDObRb)436 Cell Metabolism 6, 431–445, December 2007 ª2007 Elsevimice. Interestingly, body weight of ob/ob-PtenDObRb
mice was unaltered as compared to ob/ob mice, both in
males (Figure 5A) and females (data not shown). Similarly,
fat pad weight was unaltered in ob/ob-PtenDObRb mice as
compared to ob/ob controls (Figure 5B). Moreover, as-
sessment of WAT histomorphology revealed no differ-
ences in ob/ob-PtenDObRb as compared to ob/ob control
mice (Figure 5C). Blood glucose concentrations (Fig-
ure 5D) and insulin sensitivity as assessed by intraperito-
neal ITT (Figure 5E) were also comparable in ob/ob-
PtenDObRb and ob/ob mice.
To address, whether central leptin administration may
lead to a similar phenotype as observed in PtenDObRb
mice on the background of an ob/ob mouse, we next
implanted ob/ob controls and ob/ob-PtenDObRb miceer Inc.
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ObRb-Specific Pten Knockout Micewith osmotic minipumps delivering leptin intracerebroven-
tricularly. Icv leptin treatment over a period of two weeks
resulted in a similar suppression of food intake in both
ob/ob controls and ob/ob-PtenDObRb mice (data not
shown). In contrast, while the initial decrease in body
weight over the first 7 days of leptin treatment was similar
in ob/ob controls and ob/ob-PtenDObRb mice, ob/ob-
PtenDObRb mice demonstrated a significantly higher de-
crease in body weight compared with ob/ob controls
from day 8 on (Figure 5F). Consistent with the phenotype
of PtenDObRb mice, histomorphological analysis of perigo-
nadal WAT of leptin-treated ob/ob-PtenDObRb mice
showed a marked decrease in WAT adipocyte size and in-
creased Ucp1 immunoreactivity (Figures 5G and 5H).
These data clearly show that inactivation of Pten in
ObRb-expressing cells fails to alleviate obesity and insulin
resistance in ob/ob mice, indicating that endogenous lep-
tin is required to activate Pi3k and to result in the observed
phenotypical changes observed in PtenDObRb mice. On
the other hand, a significantly increased reduction in
body weight and occurrence of WAT to BAT transdifferen-
tiation in icv leptin-treated ob/ob-PtenDObRb animals dem-
onstrates that leptin action in the CNS accounts for WAT
transdifferentiation as a consequence of enhanced lep-
tin-mediated Pi3k activation in leptin’s target neurons of
the CNS.
Enhanced Glucose Metabolism in PtenDObRb Mice
To assess the effect of the significantly reduced body
weight and fat mass of PtenDObRb mice on glucose ho-
meostasis, we initially tested glucose and insulin tolerance
in these mice. These analyses revealed both significantly
improved glucose tolerance (Figure 6A) and insulin sensi-
tivity (Figure 6B) in male and female PtenDObRb mice as
compared to the respective controls. Consistently, both
PtenDObRb males and females exhibited markedly reduced
serum insulin levels (Figure 6C), mirroring enhanced insu-
lin sensitivity in PtenDObRb mice. To further investigate
whether this increase in glucose homeostasis was caused
by additional changes in insulin secretion, we measured
serum insulin levels following intravenous glucose injec-
tion. This analysis showed the typical biphasic pattern of
insulin secretion upon glucose injection in PtenDObRb and
control mice, which was not altered in magnitude, indicat-
ing unaltered insulin secretion in PtenDObRb mice (Fig-
ure S4A). Moreover, histomorphological assessment of
pancreata from PtenDObRb failed to reveal alterations in is-
let size, number, or composition (Figure S4B). These data
show that the observed increase in glucose homeostasis
in PtenDObRb mice is mostly due to enhanced peripheral in-
sulin sensitivity rather than altered glucose-stimulated in-
sulin secretion.
To further characterize glucose homeostasis, we per-
formed hyperinsulinemic-euglycemic clamp studies in
mice at the age of 19 weeks. In line with the results
observed in the insulin and glucose tolerance tests, the
glucose infusion rate (GIR) taken here as an indicator of in-
sulin sensitivity was significantly higher in PtenDObRb as
compared to control mice (Figure 6D). Assessment ofCell Methe tissue-specific glucose uptake rates revealed signifi-
cantly increased glucose uptake in skeletal muscle of
PtenDObRb mice, while this remained unaltered in the brain
(Figure 6E). On the other hand, insulin-induced suppres-
sion of hepatic glucose production (HGP) did not signifi-
cantly differ between the two groups: insulin equally sup-
pressed HGP by 80% in PtenDObRb and control mice
(Figure 6F). Taken together, these data demonstrate that
increased insulin sensitivity in PtenDObRb mice is the con-
sequence of improved insulin action in peripheral insulin
target tissues, which most likely occurs secondarily to
leanness and WAT transdifferentiation.
DISCUSSION
In addition to regulating food intake, leptin controls body
weight in part through regulation of SNA (Campfield
et al., 1995; Halaas et al., 1995; Haynes et al., 1997; Pel-
leymounter et al., 1995). Despite the Pi3k pathway being
suggested as the common endpoint for anorectic action
mediated by either leptin or insulin (Niswender et al.,
2001, 2003), it is still not clear whether this is also the
case for the regulation of peripheral sympathoactivation.
Icv insulin administration has previously been shown to
produce region-specific peripheral sympathoactivation
via stimulation of hypothalamic Pi3k- and MAPK-depen-
dent signaling (Rahmouni et al., 2004). While insulin’s abil-
ity to activate renal sympathetic outflow was blocked by
Pi3k inhibition, sympathetic outflow to BAT was selec-
tively inhibited by blocking MAPK activation (Rahmouni
et al., 2004). Similarly, the increase in renal sympathoacti-
vation induced by icv leptin was abolished by coadminis-
tration of Pi3k inhibitors (Rahmouni et al., 2004). These ex-
periments are consistent with our finding of unaltered BAT
mass and selective reduction of both perigonadal and par-
arenal WAT in PtenDObRb mice (data not shown). These
data clearly indicate that SNA of peripheral organs is se-
lectively regulated via distinct leptin-stimulated intracellu-
lar signaling pathways. Consistent with the notion that lep-
tin can regulate SNA of peripheral tissues, short-term
peripheral leptin treatment of ob/ob mice has previously
been shown to induce Ucp1 expression in WAT and BAT
as this was taken as indirect evidence for increased SNA
of these tissues (Commins et al., 1999). Nevertheless,
these experiments did not address the following five key
questions: (1) Does leptin-stimulated Pi3k activation result
in increased Ucp1 expression in WAT of wild-type mice?
(2) If so, is this effect mediated via central or peripheral lep-
tin action? (3) If mediated by central leptin action, is the
observed inhibitory effect on SNA due to blocking Pi3k
in primary leptin-responsive neurons or is Pi3k activity re-
quired in second-order downstream effector neurons? (4)
Is activation of the Pi3k pathway in ObRb-expressing cells
not only necessary but also sufficient to stimulate sympa-
thetic outflow to WAT? (5) Most importantly, does chronic
selective activation of this branch of leptin signaling have
any impact on energy homeostasis and steady-state body
weight?tabolism 6, 431–445, December 2007 ª2007 Elsevier Inc. 437
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ObRb-Specific Pten Knockout MiceFigure 4. Transdifferentiation of Perigonadal White Adipose Tissue in PtenDObRb Mice
(A) HE stain of epididymal adipose tissue of two different male PtenDObRb (right panels) and control (Co, left panels) mice, aged 20 weeks, on a normal
rodent chow diet. Scale bar: 1000 mm.
(B) Quantification of the mean adipocyte size in epididymal WAT of male PtenDObRb and control mice, aged 20 weeks, on a normal rodent chow diet
(n = 3).
(C) Ucp1 immunohistochemistry of epididymal WAT of male PtenDObRb (right panels) and control (Co, left panels) mice, aged 20 weeks, on a normal
rodent chow diet. The bottom panels show one of the upper adipose tissues in a higher magnification. Scale bars: 500 (upper) and 100 (lower) mm.
Note the presence of multiple vacuoles (indicated by the arrowheads) in WAT of PtenDObRb mice.
(D) Quantification of Ucp1 protein expression in perigonadal WAT of female PtenDObRb and control (Co) mice aged 20 weeks (n = 4).
(E) Ultrastructural analysis of perigonadal WAT in PtenDObRb and control (Co) mice aged 20 weeks. Scale bars: 10 (upper) and 2 (lower) mm. Note the
high abundance of mitochondria in WAT of PtenDObRb mice (lower right picture).438 Cell Metabolism 6, 431–445, December 2007 ª2007 Elsevier Inc.
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ObRb-Specific Pten Knockout MiceThe present study clearly establishes that Pi3k activa-
tion in primary leptin-responsive neurons of the CNS as
characterized by ObRb expression regulates SNA of
WAT and pararenal fat tissue and as a consequence leads
to BAT-like remodeling of WAT with increased mitochon-
dria content and Ucp1 expression, resulting in increased
energy expenditure and leanness.
The notion that Cre-mediated recombination occurred
only in distinct hypothalamic nuclei of ObRbCre mice is
surprising, given that ObRb expression has been also de-
scribed in peripheral organs. As depicted in Figure 1, the
ObRbCre in the present study targets a subset of hypotha-
lamic Pomc, AgRP, and other unidentified ARC neurons
as well as neurons of the VMH and DMH but notably not
in any other brain areas analyzed. Such findings are con-
sistent with previous ObRb expression studies (Fei et al.,
1997), and they can also be explained by different levels
of ObRb expression in hypothalamic neurons versus cells
of peripheral organs. While hypothalamic ObRb expres-
sion was detectable by northern blot analyses on RNA iso-
lated from whole brain, indicating very high abundance of
ObRb in hypothalamic neurons, ObRb expression in adi-
pose tisssue could only be detected in RNase protection
assays (Fei et al., 1997), pointing to a far lower expression
level. Since Cre is expressed from an IRES located in the
30 untranslated region of the Lepr gene this results in
a lower expression level of the transgene than that of the
Lepr gene itself. Moreover, as the transgene was only
used in the heterozygous state, it is reasonable to postu-
late that Cre is only expressed in cells with highest expres-
sion of ObRb. In other words, it is expressed in the primary
leptin-responsive neurons in the hypothalamus and not in
peripheral organs exhibiting low abundance of ObRb ex-
pression. This notion is further supported by data derived
from western blot, Southern blot, and reporter gene ap-
proaches, for which we did not detect Cre-mediated re-
combination in extrahypothalamic cell types. Thus, the
phenotype reported in this study is clearly the result of
Pten inactivation in leptin-targeted CNS neurons, a notion
which is further substantiated by the more profound effect
of centrally versus peripherally applied leptin on WAT
SNA. This is further supported by the finding of unaltered
circulating plasma catecholamine concentrations in
PtenDObRb mice (data not shown).
Although the exact nature of hypothalamic leptin-re-
sponsive neurons responsible for this phenotype is not
clear at this stage, it is in all probability that this effect is
not a result of Pten inactivation in Pomc neurons. We
have recently reported that Pten ablation specifically in
Pomc-expressing hypothalamic neurons leads to leptin-
resistant hyperphagia and obesity due to activation ofCell MetaKATP channels and subsequent inactivation of hypotha-
lamic Pomc neurons (Plum et al., 2006a, 2006b). In light
of these data, we speculate that Pten ablation in different
types of ObRb-expressing hypothalamic neurons leads to
Pi3k-stimulated activation of KATP channels, thus inacti-
vating a part of the orexigenic (i.e., Pomc) and anorexi-
genic (i.e., AgRP) neurons. Indeed, we reported that insu-
lin hyperpolarizes AgRP neurons via activation of KATP
channels, most likely as a consequence of Pi3k activation
(Konner et al., 2007). We have also previously shown that
ablation of AgRP neurons in adult mice rapidly causes
deadly anorexia, while ablation of hypothalamic Pomc
neurons leads to a slow-onset of mild hyperphagia (Gropp
et al., 2005). Thus, we hypothesize that simultaneous
AgRP neuron-intrinsic inactivation of Pten may account
for reversing the hyperphagia resulting from Pten inactiva-
tion in Pomc neurons. Preliminary experiments showed
that indeed AgRP-restricted Pten deficiency results in
leanness but strikingly not in transdifferentiation of WAT
to a BAT-like structure as described in this manuscript
(A.C.K. and J.C.B., unpublished data). Taken together,
these findings suggest that the regulation of sympathetic
outflow to WAT is regulated by neurons other than Pomc
or AgRP cells. Thus, further studies will have to identify
the exact anatomical site and nature of ObRb-expressing
hypothalamic neurons responsible for mediating SNA of
WAT.
The observation of unaltered WAT mass without histo-
morphological changes in ob/ob-PtenDObRb mice demon-
strates that endogenous leptin is required to increase SNA
in WAT of SNA PtenDObRb mice, whereas icv leptin treat-
ment results in a more pronounced weight reduction and
WAT remodeling in ob/ob-PtenDObRb compared to ob/ob
mice. Therefore, the present study clearly defines a path-
way where sensitization of leptin-stimulated Pi3k activity
in hypothalamic neurons accounts for the observed phe-
notype. Future experiments will be required to clarify
whether SNA stimulates expansion of BAT precursors
present in WAT or initiates true transdifferentiation of es-
tablished white adipocytes. Whatever cell type is respon-
sible for this phenomenon, this study reveals a potential
target for the treatment of obesity and insulin resistance.
Remarkably, the phenotype of PtenDObRb mice resem-
bles that resulting from inactivation of the alternative
PIP3-phosphatase SH2-containing inositol phosphatase
(Ship)-2 (Sleeman et al., 2005). Although histological fea-
tures and Ucp1 expression in WAT were not reported in
that study, Ship-2-deficient mice exhibited upregulation
of Ucp3 expression in skeletal muscle and improvement
of muscle insulin action. A significant increase of Ucp3 ex-
pression in skeletal muscle was not detectable in our(F) Representative recordings of perigonadal WAT sympathetic nerve activity (SNA) obtained in one control and one PtenDObRb female mouse at base-
line and in response to intravenous administration of 60 mg leptin.
(G) Quantification of the leptin-induced increase in perigonadal WAT SNA of female control and PtenDObRb mice after systemic leptin treatment
(n = 4–5).
(H) Quantification of the leptin-induced increase in perigonadal WAT SNA of female control and PtenDObRb mice after icv leptin treatment (n = 5–6).
Filled symbols depict PtenDObRb mice, open symbols control mice. Displayed values are means ± SEM. PtenDObRb versus Co: #, p % 0.05; z,
p% 0.01; *, p% 0.001.bolism 6, 431–445, December 2007 ª2007 Elsevier Inc. 439
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ObRb-Specific Pten Knockout MiceFigure 5. Effect of Pten Ablation in Leptin-Deficient ob/ob Mice
(A) Average body weights of male ob/ob-PtenDObRb (n = 12–19) and ob/ob control (n = 12–20) mice on a normal rodent chow diet.
(B) Quantification of perigonadal fat pad weights corrected for body weight (relative perigonadal fat pad weights) of male (n = 8–9) mice aged
14 weeks.
(C) Representative HE stain of epididymal adipose tissue of an ob/ob-PtenDObRb (right panel) as compared to an ob/ob (left panel) male mouse, aged
14 weeks, on a normal rodent chow diet. Scale bar: 500 mm.
(D) Average blood glucose levels of male ob/ob-PtenDObRb (n = 8) and ob/ob control (n = 9) mice on a normal rodent chow diet at the age of 10 weeks.
(E) Intraperitoneal insulin tolerance tests in male ob/ob-PtenDObRb (n = 8) and ob/ob control (n = 9) mice aged 14 weeks.
(F) Average relative body weight of ob/ob-PtenDObRb (n = 4–6) and ob/ob control (n = 4–7) mice during 13 days of continuous icv leptin treatment with
osmotic mini pumps.
(G) Representative HE stain of epididymal adipose tissue of an ob/ob-PtenDObRb (right panel) as compared to an ob/ob (left panel) male mouse on
a normal rodent chow diet after 13 days of continuous icv leptin treatment with osmotic mini pumps. Scale bars: 1000 (upper) and 500 (lower) mm.440 Cell Metabolism 6, 431–445, December 2007 ª2007 Elsevier Inc.
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ObRb-Specific Pten Knockout Micemodel (data not shown). However, since Ship-2 is also ex-
pressed in the CNS, our study supports the possibility that
the observed phenotype in Ship-2-deficient mice may
also arise in part from inactivation of this PIP3-phospha-
tase in the CNS.
Besides its metabolic benefits, conditional knockout of
Pten in peripheral tissues has been found to also produce
undesirable effects, i.e., (1) Pten deletion in pancreatic
b cells (PtenDRip) leads to islet hyperplasia (Stiles et al.,
2006), (2) mice with adipocyte-specific disruption of Pten
(PtenDaP2) exhibit improved glucose metabolism (Kurla-
walla-Martinez et al., 2005), (3) liver-specific Pten knock-
out mice (PtenDAlb) exhibit improved systemic glucose tol-
erance but present with hepatomegaly, fatty liver
phenotype, and hepatic tumorigenesis (Stiles et al.,
2004), and (4) muscle-specific Pten disruption (PtenDMck)
appears to prevent diet-induced obesity and insulin resis-
tance but does not alter insulin sensitivity under normal
diet conditions (Wijesekara et al., 2005). Contrariwise,
we show here that inactivation of Pten specifically in cen-
tral ObRb-expressing neurons appears to be beneficial for
energy homeostasis and glucose metabolism. These data
clearly demonstrate the essential importance of the CNS
when targeting molecular pathways in the treatment of
obesity and type 2 diabetes mellitus.
While the transdifferentiation of perigonadal WAT ap-
pears to be a direct effect of increased hypothalamic lep-
tin signaling via Pi3k, the enhanced glucose metabolism
most likely represents a secondary effect resulting from in-
creased Ucp1 expression in perigonadal WAT and subse-
quent leanness. Indeed, Yamada et al. recently reported
that ectopic expression of Ucp1 in epididymal WAT of
obese mice reversed insulin and leptin resistance inde-
pendent of leptin (Yamada et al., 2006). Therefore, altering
sympathetic outflow from hypothalamic neurons to peri-
gonadal WAT provides not only an efficient way for reduc-




Care of all animals was within institutional animal care committee
guidelines, and all procedures were approved by local government au-
thorities and were in accordance with NIH guidelines. Mice were
housed in groups of 3–5 at 22C –24C using a 12 hr light/12 hr dark
cycle with lights on at 06:00 hr. Animals were fed either regular chow
food (Teklad Global Rodent # T.2018.R12; Harlan, Germany) contain-
ing 53.5% carbohydrates, 18.5% protein, and 5.5% fat (12% of calo-
ries from fat) or a high-fat diet (# C1057; Altromin, Germany) with
32.7%, 20%, and 35.5% of carbohydrates, protein, and fat (55.2%
of calories from fat), respectively. Animals had ad libitum access to
water at all times, and food was only withdrawn if required for an exper-
iment. Body weight was measured once a week; body length (naso-Cell Meanal length) was measured once at week 20. Genotyping was per-
formed by PCR, using genomic DNA isolated from tail tips. At the
end of the study period of 20 weeks, animals were sacrificed in isoflur-
ane anesthesia.
Generation of ObRbCre-Ptenlox/lox Mice
ObRbCre mice were mated with Ptenlox/lox mice, and a breeding col-
ony was maintained by mating Ptenlox/lox with ObRbCre-Ptenlox/lox
mice. Only animals from the same mixed background strain generation
were compared to each other. All stated genotypes were stable over at
least three generations.
Western Blot Analysis
Tissues were removed, placed in homogenization buffer, and sub-
jected to a polytron homogenizer. Western blot analyses were per-
formed as previously described (Schubert et al., 2004) with primary an-
tibodies raised against Pten (# MS-1250-P; NeoMarkers, CA, USA),
insulin receptor b subunit (# sc-711; Santa Cruz Biotechnology, Inc.,
CA, USA), Ucp1 (# sc-6528; Santa Cruz Biotechnology), or b-actin
(# 03-3100; Molecular Probes/Invitrogen GmbH, Germany). Optical
density was quantified using AIDA software (Version 4.00.027; Rayt-
est, Straubenhardt, Germany).
Analytical Procedures
Blood glucose values were determined from whole venous blood using
an automatic glucose monitor (GlucoMen GlycO´; A. Menarini Diagnos-
tics, Italy). Serum insulin and leptin levels as well as plasma catechol-
amine levels were measured by ELISA using mouse standards accord-
ing to the manufacturer’s guidelines (Mouse Leptin ELISA, Mouse/Rat
Insulin ELISA; Crystal Chem, IL, USA; CatCombi ELISA for Epinephrine
and Norepinephrine; IBL, Hamburg, Germany).
Food Intake, Indirect Calorimetry, Physical Activity, and Body
Core Temperature Determination
Food intake was measured over 3 weeks in a regular cage using racks,
which were weighed once a week, and daily food intake was calcu-
lated as the average intake of chow within the time stated.
All measurements were performed with a Comprehensive Labora-
tory Animal Monitoring System (CLAMS, Oxymax Windows 3.0.3; Co-
lumbus Instruments, OH, USA). Chemically disinfected transmitters
(PDT-4000 E-Mitter, VitalView Data Acquisition System 4.1; Mini Mitter
Company, Inc., OR, USA) were implanted into the peritoneal cavity of
mice, which had been anesthetized by intraperitoneal injection of aver-
tin (2,2,2-tribromoethanol and tert-amyl alcohol; Sigma-Aldrich, Ger-
many). After a recovery period of 7 days, mice were placed at room
temperature (22C–24C) in 3.0-l chambers of the CLAMS open circuit
calorimetry. Settling time was set at 150 s and measuring time at 60 s
with room air as reference. Food and water were ad libitum provided in
the appropriate devices. Mice were allowed to acclimatize in the
chambers for 24 hr. Locomotor activity, body temperature, and param-
eters of indirect calorimetry were measured for at least the following
72 hr. Presented data are average values obtained in these recordings.
Hypothalamic Neuropeptide Expression
Neuropeptide mRNA was analyzed using quantitative RT-PCR. RNA
was extracted from hypothalamic blocks using the QIAGEN RNeasy
Kit (QIAGEN, Germany). Hypothalamic RNA was reverse transcribed
with SuperScript Reverse Transcriptase (Invitrogen, Life Technologies,
CA, USA) and amplified using TaqMan Universal PCR-Master Mix, NO
AmpErase UNG with TaqMan Assay on demand kits (Applied Biosys-
tems, CA, USA) with the exception of the detection of Pomc mRNA,(H) Representative Ucp1 immunohistochemistry of epididymal WAT of male ob/ob PtenDObRb (right panels) and ob/ob control (Co, left panels) mice on
a normal rodent chow diet after 13 days of continuous icv leptin treatment with osmotic mini pumps. The bottom panels show one of the upper ad-
ipose tissues in a higher magnification. Scale bars: 500 (upper) and 100 (lower) mm.
Black symbols depict ob/ob-PtenDObRb mice, light gray symbols ob/ob control mice. Displayed values are means ± SEM, PtenDObRb versus Co: #,
p% 0.05.tabolism 6, 431–445, December 2007 ª2007 Elsevier Inc. 441
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ObRb-Specific Pten Knockout MiceFigure 6. Enhanced Glucose Metabolism in PtenDObRb Mice
(A) Intraperitoneal glucose tolerance tests in male (upper panel, n = 15–48) and female (lower panel, n = 16–49) mice aged 10 weeks.
(B) Intraperitoneal insulin tolerance tests in male (upper panel, n = 12–38) and female (lower panel, n = 16–44) mice aged 11 weeks.
(C) Serum insulin levels of male (n = 8–23) and female (n = 7–35) mice aged 15 weeks.
(D) Blood glucose levels (upper left panel), glucose infusion rates (lower left panel), and area under the glucose-infusion-rate curve (AUC) during the
clamp period (hatched area and lower right panel) in control and PtenDObRb mice.
(E) Tissue-specific insulin-stimulated glucose uptake rates in control and PtenDObRb mice.
(F) Suppression of hepatic glucose production by insulin as measured under steady-state conditions during the clamp.
Filled symbols depict PtenDObRb mice, open symbols control mice. Displayed values are means ± SEM. PtenDObRb versus Co: #, p % 0.05; z,
p% 0.01; *, p% 0.001.442 Cell Metabolism 6, 431–445, December 2007 ª2007 Elsevier Inc.
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50-GAC ACG TGG AAG ATG CCG AG-30; antisense, 50-CAG CGA
GAG GTC GAG TTT GC-30; probe sequence, 50-FAM-CAA CCT GCT
GGC TTG CAT CCG G-TAMRA-30. Relative expression of neuropep-
tide mRNA was determined using standard curves based on hypotha-
lamic cDNA and samples were adjusted for total RNA content by
TATA-box binding protein (TBP) RNA quantitative PCR. Calculations
were performed by a comparative method (2-ddCT). Quantitative PCR
was performed on an ABI-PRISM 7700 Sequence Detector (Applied
Biosystems, Germany). Assays were linear over 4 orders of magnitude.
Statistical Methods
Data sets were analyzed for statistical significance with Student’s t
test. Prior to performing t tests, homogeneity of variances was tested
for by F-Test, and resulting values were compared to the critical values
of the F distribution table at the respective a levels. Accordingly, homo-
scedastic or heteroscedastic unpaired t test was performed in the case
of homogeneous or nonhomogeneous variances, respectively. In one
case, i.e., the comparison between body weights of ob/ob-PtenDObRb
and ob/ob control mice before and after leptin treatment, a paired t test
was performed (Figure 5F). The threshold for statistical significance
was selected at p < 0.05.
Histomorphological and Immunocytochemical Procedures—
Adipose Tissue
For histomorphological assessment of WAT, dissected tissues were
incubated in fixation solution containing 4% paraformaldehyde at
4C overnight and embedded in paraffin according to standard proto-
cols. Tissue blocks were cut into 7 mm sections on a sliding microtome
and mounted onto gelatin-coated slides. Following deparaffinization
(20 min Xylol, 2 min Isopropanol, 2 min 96% ethanol, 2 min 75% etha-
nol), slides were washed in PBS and subsequently HE or immunohis-
tochemically stained as a prelude to performing histomorphological
assessment.
For Ucp1 straining, epitope retrieval was performed using the stan-
dard citrate buffer epitope retrieval method, sections were then rinsed
in PBS twice and incubated with normal donkey serum blocking solu-
tion (2% donkey serum, 1% BSA, 0.1% cold fish skin gelatin, 0.1%
Triton X-100, 0.05% Tween, 0.05% sodium azide, 0.01M PBS, pH
7.2) for 30 min at room temperature to block nonspecific binding of im-
munoglobulin. Sections were subsequently incubated with goat anti-
Ucp1 antibody (#sc-6528, Santa Cruz Biotechnology; diluted 1:100
in primary antibody dilution buffer containing 1% BSA, 0.1% cold
fish skin gelatin, 0.05% sodium azide, and 0.01M PBS, pH7.2) for
1 hr at room temperature. Sections were again rinsed twice in PBS, in-
cubated in peroxidase blocking solution (3% H2O2 in PBS) for 10 min to
block endogenous peroxidase activity, extensively rinsed in PBS, and
incubated with biotinylated donkey anti-goat IgG (Jackson ImmunoR-
esearch Laboratories, Inc., UK; diluted 1:1000 in blocking solution) for
30 min at room temperature. Following three rinses in PBS, sections
were incubated with HRP-Streptavidin diluted in PBS for 30 min at
room temperature, extensively rinsed in PBS, incubated in DAB perox-
idase substrate solution for 5–10 min, rinsed briefly in distilled water,
and counterstained with Mayer’s hematoxylin solution. Sections
were coverslipped with glycerine gelatine.
Stained sections were viewed under a Zeiss Axiophot and pictures
were taken with a digital color camera (Spot Diagnostic Instruments,
Inc., MI, USA) using Spot Advanced 3.0.3 software. The determination
of the mean adipocyte size and adipocyte size distribution was carried
out in HE-stained tissues. The cell sizes of all (approximately 200–400)
adipocytes within the field of view/picture were determined in adipose
tissue slices of three independent animals per group using Zeiss Axio-
Vision 4.2 software.
Immunocytochemical Procedures—Hypothalamic Tissues
For assessment of pStat3 generation, ad libitum fed mice were intrave-
nously injected with either saline or 20 mg leptin and anesthetized after
30 min. For assessment of pAkt generation, overnight (20 hr) fastedCell Memice were intravenously injected with either saline or 100 mg leptin
and anesthetized after 20 min. Mice were then perfused transcardially
with saline followed by fixation solution containing 4% paraformalde-
hyde. Brains were dissected and post-fixated in fixation solution at
4C overnight and soaked in 20% sucrose solution for cryoprotection
for at least 6 hr. Cryoprotected tissues were frozen on dry ice and cut
into 30 or 25 mm coronal sections on a sliding microtome for pStat3 or
pAkt staining, respectively, collected in four series, and stored in anti-
freeze solution (50% PBS, 15% ethyl glycol, 35% glycerol) at 20C.
Free-floating tissue sections were extensively washed to remove cryo-
protectant and pretreated with H2O2 (0.3% in PBS) for 30 min to block
endogenous peroxidase. After washing, sections were blocked for 1 hr
(3% normal goat serum in PBS, 0.4% Triton X-100, 0.2% sodium-
azide) followed by incubation of anti-pStat3 (1:3000 diluted in blocking
solution; Cell Signaling, MA, USA; 1:1000), pAkt (1:1000 diluted in
blocking solution; #9277; Cell Signaling), or anti-GFP (#A6455, Molec-
ular Probes, OR, USA; 1:10000 diluted in antibody diluent; DAKO, Ger-
many) antibody for 48 hr at 4C. Sections were extensively washed in
PBS, incubated for 2 hr at room temperature in biotinylated anti-rabbit
antibody (Vector, CA, USA; 1:200 diluted in blocking solution without
sodium azide), washed again, and then incubated in ABC solution
for 1 hr at room temperature. Sections were rinsed in PBS, incubated
in DAB (0.4%) and H2O2 (0.01%) for 4–6 min, rinsed again, mounted
onto gelatin-coated slides, dried, and coverslipped using mounting
media (ProLong Gold; Molecular Probes). Representative pictures of
the ARC were taken with a digital color camera (DP70; Olympus).
For quantification of pStat3-positive cells, tissues were processed
as described, and pictures from every 4th section throughout the
ARC (generally 12–13 adjacent sections Bregma 1.1 mm to
2.7 mm) were taken, and all sections were allocated in a rostral to
caudal manner to visualize the distribution of Pomc neurons through-
out the ARC. Using Adobe Photoshop software, pStat3-positive neu-
rons, which were found in the ARC, the DMH, and the VMH, were
counted and marked digitally to prevent multiple counts as previously
described (Plum et al., 2006b). Cell counts were performed in four an-
imals per group. Cell numbers represent every 4th section throughout
the ARC.
Quantification of pAkt-positive cells was performed analogously.
Cell counts were performed in every 4th section (eight sections/animal)
starting at bregma 1.46 mm, and cell numbers represent the average
total number of cells counted in three animals per group.
Recording of Sympathetic Nerve Activity
Multifiber recording was used to compare perigonadal adipose tissue
SNA between wild-type and PtenDObRb mice at baseline and in re-
sponse to leptin. Mice were anesthetized by intraperitoneal injection
with ketamine (91 mg/kg) and xylaxine (9.1 mg/kg). To measure perigo-
nadal adipose tissue SNA, a nerve fascicle to the left perigonadal
adipose tissue was carefully isolated. A bipolar platinum-iridium elec-
trode (Cooner Wire, CA, USA) was suspended under the nerve and se-
cured with silicone gel (Kwik-Cast; World Precision Instruments, FL,
USA). The nerve signal was amplified and filtered as described previ-
ously (Rahmouni et al., 2004).
Baseline SNA was recorded for 10 min followed by either intra-
venous or icv bolus administration of leptin (60 mg and 2 mg, respec-
tively). SNA response to leptin was recorded continuously for 240 min.
Anesthesia was sustained with the administration of a-chloralose
(25 mg/kg/hr) intravenously. Body temperature was maintained at
37.5C with the assistance of a lamp and a heating pad. At the end
of the study, mice were euthanized with a lethal dose of ketamine/
xylazine, and weight of fat pads was measured. The integrated voltage
after death (background noise) was subtracted from the total inte-
grated voltage to calculate real WAT SNA.
Hyperinsulinemic-Euglycemic Clamp Studies in Awake Mice
Catheter Implantation
At age 18 weeks, male mice were anesthetized by intraperitoneal
injection of avertin and adequacy of the anesthesia was ensured bytabolism 6, 431–445, December 2007 ª2007 Elsevier Inc. 443
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Braintree Scientific Inc., MA, USA) was inserted into the right internal
jugular vein, advanced to the level of the superior vena cava, and se-
cured in its position in the proximal part of the vein with 4-0 silk; the
distal part of the vein was occluded with 4-0 silk. After irrigation with
physiological saline solution, the catheter was filled with heparin
solution and sealed at its distal end. The catheter was subcutane-
ously tunneled, thereby forming a subcutaneous loop, and exterior-
ized at the back of the neck. Cutaneous incisions were closed with
a 3-0 silk suture and the free end of the catheter was attached to
the suture in the neck as to permit the retrieval of the catheter on
the day of the experiment. Mice were intraperitoneally injected with
1 ml of saline containing 15 mg/g body weight of tramadol (Tramal,
Gru¨nenthal, Germany) and placed on a heating pad in order to facil-
itate recovery.
Clamp Experiment
Only mice that had regained at least 90% of their preoperative body
weight after 6 days of recovery were included in the experimental
groups. After starvation for 15 hr, awake animals were placed in re-
strainers for the duration of the clamp experiment. After a D-[3-3H]Glu-
cose (Amersham Biosciences, UK) tracer solution bolus infusion
(5 mCi), the tracer was infused continuously (0.05 mCi/min) for the dura-
tion of the experiment. At the end of the 40 min basal period, a blood
sample was collected for determination of the basal parameters. To
minimize blood loss, red blood cells were collected by centrifugation
and reinfused after being resuspended in saline. Insulin (human regular
insulin; NovoNordisk Pharmaceuticals, Inc., NJ, USA) solution contain-
ing 0.1% BSA (Sigma-Aldrich, Germany) was infused at a fixed rate
(4 mU/g/min) following a bolus infusion (40 mU/g). Blood glucose levels
were determined every 10 min (B-Glucose Analyzer; Hemocue AB,
Sweden) and physiological blood glucose levels (between 120 and
150 mg/dl) were maintained by adjusting a 20% glucose infusion (Del-
taSelect, Germany). Approximately 60 min before steady state was
achieved, a bolus of 2-Deoxy-D-[1-14C]Glucose (10 mCi, Amersham)
was infused. Steady state was defined as reached when glucose mea-
surements were constant for at least 30 min at a fixed glucose infusion
rate and was achieved within 100 to 130 min. During the clamp exper-
iment, blood samples were collected after the infusion of the 2-Deoxy-
D-[1-14C]Glucose at the time points 0, 5, 15, 25, 35 min, etc. until
reaching the steady state. During the steady state, blood samples
for the measurement of steady-state parameters were collected. At
the end of the experiment, mice were killed by cervical dislocation,
and brain, liver, and skeletal muscle tissue were dissected and stored
at 20C. WAT was not collected because PtenDObRb males, which
had been fasted overnight, did not possess any residual epididymal
WAT.
Assays
Plasma [3-3H]Glucose radioactivity of basal and steady PtenDObRb
samples was determined directly after deproteinization with 0.3 M
Ba(OH)2 and 0.3 M ZnSO4 and also after removal of
3H2O by evapora-
tion, using a liquid scintillation counter (Beckmann, Germany). Plasma
Deoxy-[1-14C]Glucose radioactivity was directly measured in the liquid
scintillation counter. Tissue lysates were processed through ion ex-
change chromatography columns (Poly-Prep Prefilled Chromatogra-
phy Columns, AG1-X8 formate resin, 200–400 mesh dry; BioRad Lab-
oratories, CA, USA) to separate 2-Deoxy-D-[1-14C]Glucose (2DG) from
2-Deoxy-D-[1-14C]Glucose-6-Phosphate (2DG6P). Steady-state
plasma glucagon levels were determined by RIA (Biotrend Chemicals,
Germany).
Calculations
Glucose turnover rate (mg3 kg13min1) was calculated as the rate
of tracer infusion (dpm/min) divided by the plasma glucose-specific
activity (dpm/mg) corrected for body weight. HGP (mg3 kg13min1)
was calculated as the difference between the rate of glucose appear-
ance and glucose infusion rate. In vivo glucose uptake for each tissue
(nmol 3 g1 3 min1) was calculated based on the accumulation of
2DG6P in the respective tissue and the disappearance rate of 2DG
from plasma as described previously (Ferre et al., 1985).444 Cell Metabolism 6, 431–445, December 2007 ª2007 ElsevieChronic Central Leptin Treatment in ob/ob-PtenDObRb Mice
icv cannulation and minipump implantation were performed in a single
surgical procedure. Mice under avertin anesthesia (240 mg/kg) (2,2,2-
tribromoethanol; Sigma) were stereotactically implanted with a sterile
osmotic pump connector cannula (Bilaney Consultants, Du¨sseldorf,
Germany) into the left lateral cerebroventricle (anteroposterior
0.2 mm, lateral +1.0 mm to bregma, and dorsoventral 2.5 mm be-
low skull). The cannula was connected to an osmotic minipump (model
1002, flow rate 0.25 ml/hr, 14 days; Alzet, Cupertino, CA) via a 65 mm
long polyvinylchloride tubing (inner diameter 0.69 mm; Alzet, Cuper-
tino, CA). Minipumps and tubings were prefilled with a body weight-
adapted dilution of leptin in aCSF to ensure a dose of 14 ng/kg/min
over 14 days of treatment. Before implantation, pumps connected to
the icv cannulae were primed overnight at 37C in 0.9% saline. Mice
were housed singly and monitored for body weights and food intake.
At the end of the experiment mice were killed by cervical dislocation
and perigonadal WAT was collected for further analysis.
Supplemental Data
Supplemental Data include four figures and can be found with this
article online at http://www.cellmetabolism.org/cgi/content/full/6/6/
431/DC1/.
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